Jon Hansen, Ph.D. Email & Phone Number

Hayward, California, US

Consulting on development and commercialization of microbial biotechnology. Microbial strain, fermentation, product and process technology development and optimization. Scout and advise on investment in novel biotechnology opportunities. Engineering design, process automation, data science / modeling, & techno-economic analysis. Successfully scaled up new.

Huntington Beach, CA, US

Responsible for research, development, scale-up, technology transfer, training and full-scale performance related to all biotechnology, process technologies, microbiology/microbial physiology, genomics, and strain development. Developed robust models of fermentation kinetics, mixing and mass transfer of multiple gases. Contribute to new engineering designs.

San Diego, California, US

Responsible for all R&D, science, technology, engineering and scale-up activities at Triton. Lead team of scientists including metabolic engineering, strain development/screening, microbial fermentation, downstream processing, product development and process engineering. Develop, implement and contribute to R&D programs for Triton. Coordinate scientific.

Gilbert, AZ, US

• Established robust fermentation capabilities and novel fermentation platform technology enabling new strategic low-cost process and product opportunities. Expanded product & strain development pipeline.
• Advanced science of core Agricultural & nutritional products while expanding IP portfolio. Progressed screening program for different formulations and numerous strains to address multiple modes of action.
• Designed and commissioned new R&D facilities for strain development, bio-chemistry, microbiology/molecular biology, fermentation, product & process development, and agricultural testing.

Heerlen, Limburg, NL

• Technical and program/project lead for renewable microbial derived diesel program in partnership with BP.
• Demonstrated feasibility of IRR, COGS and capital targets using an integrated flow-sheet approach, beginning with the end in mind, to set clear objectives for teams and foster collaborative innovation. On time & budget.
• Developed novel very high throughput strain screening/improvement technology, metabolic engineering toolbox, chemical conversion and downstream development capabilities targeting best-in-class solutions.
• Demonstrated breakthrough improvements in extraction & recovery efficiency with enabling novel low-cost process optimization.
• Demonstrated breakthrough improvements in productivity, feedstock efficiency, metabolic rates, titer, improved economics and improved fatty acid composition through strain and fermentation process improvements.
• Developed a comprehensive technology program, with alignment from a broad range of experts and stakeholders across multiple sites, to achieve business objectives for DSM Hydrocolloids based in China.

• Provide strategic and technical direction to major programs and external collaborations. Expand Martek product pipeline. Manage R&D organization with budget over $10 million/year.
• Established partnership between Martek and British Petroleum to develop novel microbial diesel technology while strategically reinforcing Martek’s core intellectual property portfolio.
• Managed all aspects of program and relationship management leading to successful collaboration achieving all objectives, working collaboratively across 6 time zones and advanced through 2 stage-gate reviews.
• Led team that commercialized EPA product (Ovega-3) and next generation DHA technology to expand adult nutritional product portfolio and secure long-term supply agreements for infant / toddler nutrition.

• Twice awarded the Henry "Pete" Linsert, Jr. Innovation Award for Discovery and Development.
• Managed R&D organization and advanced competencies across 2 sites with budget > $6 million/year including fermentation, process engineering, culture collection, strain development and strain performance testing.
• Provided direct support to manufacturing and commercial groups to ensure technology to ensure technology is translated to commercial reality as effectively as possible.
• Key thought leader initiating and leading teams to develop core technology for new programs including bacterial chondroitin, proteins, EPA, high potency DHA, and next generation infant formula.
• Developed novel organism and process technology for next generation infant formula and high EPA product.
• Led metabolic engineering program leading to significant improvements in DHA concentration, productivity, carbon conversion efficiency and carbon footprint.

• Managed pilot fermentation facilities in Kentucky and in Maryland. Design and built a novel pilot fermentation facility to support business needs of both R&D and manufacturing/operations.
• Build and led effective R&D organization from 8 to over 25 personnel.
• Led development and scale-up of technology leading to breakthrough improvement in performance of flagship DHA, ARA and animal feed products.
• Managed growth of capital (> $5 million/yr) and expense (up to $6 million/yr) budgets for department.
• Designed and managed pilot plant and facilities at two sites, including novel fermentation skids > 3500 L with both bubble column and agitation, with advanced on- and off-line analytical & automation capabilities.

• Built and managed Fermentation Sciences organization, pilot/lab infrastructure and R&D programs at 2 sites. Led development and commercialization of core technology for Martek’s flagship products.
• Led very successful scale-up, technology transfer and continuous improvement efforts in manufacturing for multiple sites and exceeded associated objectives allowing flagship product to become profitable.
• Contributed to the design and start-up of fermentation expansions. Expansion design team for Kingstree manufacturing facility that added over 2 million liters of new capacity.

Atlanta, Georgia, US

• Led $10 million program to achieve 5% improvement in Process Capability across 3 manufacturing sites using advanced process automation, supervisory control, optimization, database infrastructure and data mining.

Atlanta, Georgia, US

• Received the Scott Bousman Distinguished Investigator award.
• Led contract research, contract manufacturing, technology transfer/scale-up and business development.
• Led fermentation/bio-transformation process development and scale-up of transgenic technology to produce natural and novel amino acids with record potency levels & yields.
• Due diligence and initial R&D phase of new technology acquisition related to vitamin D production.

Atlanta, Georgia, US

• Led development and commercialization of core technology for CP Kelco’s flagship products.
• Led $30 million program for 3 sites, in US and UK, to achieve 15% in productivity, 10% lower manufacturing costs, 10% lower regulated chemicals, and 10% fewer raw materials with zero safety incidents.
• Developed and commercialized core technology for cost-effective production of docosahexaenoic acid (DHA) from micro-algae, with 50% increase in productivity and potency leading to strong IP, now owned by DSM.

Mclean, Virginia, US

Developed and programmed advanced models for continuous heat and mass-transfer based food unit operations.

Developed and programmed advanced model-based adaptive control strategies for continuous heat and mass-transfer based food unit operations. Technology was implemented for Nabisco products such as Premium Crackers, Fig Newtons and Planters Peanuts.

Ph.D., Chemical And Biochemical Engineering

M.S., Engineering

B.S., Chemical Engineering